Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

NCT: NCT06462729 · RECRUITING

NCT IDNCT06462729
StatusRECRUITING
Start Date2024-11-12
Completion2027-12

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of LDGraft (investigational device) compared to 100% human tissue product allograft bone (control) when applied in an ALIF procedure in the treatment of patients with lumbar degenerative disc disease (DDD).

Frequently Asked Questions

What is LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)?

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) is a clinical trial registered under NCT06462729. Current status: RECRUITING.

What is the status of NCT06462729?

The current status of NCT06462729 (LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)) is: RECRUITING.

When did LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) start?

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) started on 2024-11-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑